Navigation Links
Vasogen Announces 2007 Year-End Results
Date:1/16/2008

l supplies 1,363 1,211

Tax credits recoverable 1,565 1,327

Prepaid expenses and deposits 787 1,384

Change in fair value of forward foreign exchange

contracts 376 -

-----------------------------------------------------------------------

27,636 40,752

Property and equipment 414 615

Acquired technology - 253

Deferred financing costs - 150

-------------------------------------------------------------------------

$ 28,050 $ 41,770

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Liabilities and Shareholders' Equity

Current liabilities:

Accounts payable $ 1,175 $ 3,369

Accrued liabilities 3,519 5,067

Current portion of senior convertible notes

payable - 8,754

-----------------------------------------------------------------------

4,694 17,190

Shareholders' equity:

Share capital:

Authorized:

Unlimited common shares, without par value

Issued and outstanding:

22,391,386 common shares (2006 - 15,665,134) 365,670 344,217

Warrants 16,725 11,390

Contributed surplus 22,744 20,347


'/>"/>

SOURCE Vasogen Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Vasogen Announces Third Quarter Conference Call and Webcast of Bio InvestorForum 2007 Presentation
2. Vasogen Announces Third Quarter 2007 Results
3. Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences
4. Vasogen Provides an Update on ACCLAIM-II Preparations
5. Vasogen and Grupo Ferrer Announce Initial Roll-out of Celacade - New Therapy for Chronic Heart Failure
6. Vasogen to Conduct Year-end 2007 Conference Call
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
9. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
10. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
11. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Investor-Edge has initiated coverage on the following ... (NASDAQ: MDVN ), Pharmacyclics Inc. (NASDAQ: ... and Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD). Free research on ... . On Wednesday, October 29, 2014, the ... Jones Industrial Average declined 0.18%, to finish the day ...
(Date:10/30/2014)... 2014 On October 26th at ... in Chicago, leading applied stem cell research scientist ... McKenna presented talks on New Techniques for Enhancing ... For Stem Cells. , Dr. Riordan focused on ... properties of AlphaGEMS that include: wound healing; inflammation ...
(Date:10/30/2014)... Ottawa, Ontario (PRWEB) October 30, 2014 ... the Spartan RX CYP2C19 System . It detects ... a non-invasive cheek swab. , The Spartan RX CYP2C19 ... medicine that has been approved in Canada. Due to ... that it may be used by healthcare professionals such ...
(Date:10/30/2014)... Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ), the leader ... company overview at the Nomura Biotechnology Conference on Thursday, November ... MA. A live webcast of the ... of the Company,s website, www.isispharm.com .  A replay will ... will be archived for a limited time. About ...
Breaking Biology Technology:Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 2Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 3Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 4Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 5Riordan-McKenna Institute Founders, Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna Present at the Mid American Regenerative and Cellular Medicine Showcase 2Riordan-McKenna Institute Founders, Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna Present at the Mid American Regenerative and Cellular Medicine Showcase 3Riordan-McKenna Institute Founders, Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna Present at the Mid American Regenerative and Cellular Medicine Showcase 4Health Canada approves first near-patient DNA test for personalized medicine 2Health Canada approves first near-patient DNA test for personalized medicine 3Isis Pharmaceuticals to Present at the Nomura Biotechnology Conference 2
... and simple way of making vaccines stable even ... by scientists at Oxford University. The British technology, ... need for fridges, freezers and associated health infrastructure. It ... in the developing world where infectious diseases kill millions ...
... ... , ... 2010 -- iCorps Technologies , a leader in delivering solid, business-driven IT solutions ... Technology Industry Association (CompTIA) is the leading trade association for the world,s information technology ...
... , Feb. 17 Anpath Group, Inc. (OTC Bulletin ... financial results for its fiscal 2010 third quarter which ended ... , The Company continued a positive trend of increased ... third quarter were $66,988 compared with revenues of ...
Cached Biology Technology:New method makes vaccines stable at tropical temperatures 2New method makes vaccines stable at tropical temperatures 3iCorps Technologies Earns CompTIA Security Trustmark™ 2iCorps Technologies Earns CompTIA Security Trustmark™ 3Anpath Group, Inc. Announces Fiscal 2010 Third Quarter Results 2Anpath Group, Inc. Announces Fiscal 2010 Third Quarter Results 3Anpath Group, Inc. Announces Fiscal 2010 Third Quarter Results 4
(Date:10/29/2014)... research presented at the Society for Integrative Oncology ... for the first time that it is possible ... readily available nutritional supplement, AHCC. ... Smith, Pharm.D., associate professor in the Department of ... of Texas Health Science Center at Houston (UTHealth) ...
(Date:10/29/2014)... on sunlight to make their food, but they also need ... scientists discovered a group of molecules in plants that shields ... Journal of the American Chemical Society , one team ... work. , Timothy Zwier and colleagues at Purdue University note ... can cause serious damage to plant DNA and, as a ...
(Date:10/29/2014)... New York City on September 19, 2014, leading geneticist ... Professor of Genome Sciences and Medicine at the University ... Philosophy of Tel Aviv University, was awarded the 2014 ... addition to her honorary degree from TAU, Prof. King ... of Medicine, and for the past 18 years she ...
Breaking Biology News(10 mins):HPV infections in women eradicated by AHCC, Japanese mushroom extract 2Geneticist and humanitarian: Prof. Mary-Claire King receives Lasker Award 2
... Scientists looking to create a potent blend of enzymes to ... have developed a test that should turbocharge their efforts. ... Molecular BioSystems , is part of a worldwide effort to ... of the food supply. It,s possible to do this today, ...
... , PHILADELPHIA - It,s well established that humans maintain ... that colonize their bodies. These organisms, collectively called the ... off pathogens, and more. There exists a long and ... composition or diversity of these bacterial populations, including cancer, ...
... from the National Cancer Centre Singapore, Duke-NUS Graduate Medical ... University (Thailand), have made a seminal breakthrough in understanding ... a rare but highly lethal form of liver cancer. ... Tan, Steve Rozen, Irinel Popescu and Vajaraphongsa Bhudhisawasdi, used ...
Cached Biology News:Crafting a better enzyme cocktail to turn plants into fuel faster 2Crafting a better enzyme cocktail to turn plants into fuel faster 3Penn researchers identify molecular link between gut microbes and intestinal health 2Penn researchers identify molecular link between gut microbes and intestinal health 3Singapore scientists expose molecular secrets of bile duct cancers from different countries 2Singapore scientists expose molecular secrets of bile duct cancers from different countries 3
Rabbit monoclonal [E227] to ZAP70 (phospho Y319) ( Abpromise for all tested applications). Antigen: Synthetic phospho peptide corresponding to residues surrounding Tyr319 of human ZAP70 Entre...
C/EBPalpha Antibody Shipping Temperature: Cold Storage Temperature: -20C...
Mouse monoclonal [GB3] to Kalinin ( Abpromise for all tested applications). entrezGeneID: 3918 SwissProtID: Q13753...
Rabbit polyclonal to VEZT ( Abpromise for all tested applications). Antigen: Full length human VEZT conjugated to GST Entrez Gene ID: 55591 Swiss Protein ID: Q9HBM0...
Biology Products: